Retatrutide 15/24/30mg

Retatrutide is a next-generation investigational peptide therapy designed to support significant weight loss, metabolic improvement, and overall metabolic health. It is a triple agonist, targeting the GLP-1, GIP, and glucagon receptors—offering a more comprehensive approach to appetite regulation, fat burning, and insulin sensitivity compared to single or dual agonist therapies like semaglutide or tirzepatide.

What’s Included:

• 1x Vial of Retatrutide

• Available Dosages: 10mg, 15mg, or 30mg

• Form: Lyophilized powder (requires reconstitution with bacteriostatic water)

Key Benefits:

• Powerful Weight Loss Effects: Clinical trials have shown Retatrutide to deliver superior fat loss results—potentially even beyond those of semaglutide or tirzepatide.

• Triple-Receptor Agonist Action: Simultaneously activates GLP-1, GIP, and glucagon receptors, supporting enhanced energy expenditure and appetite suppression.

• Improves Insulin Sensitivity: Helps lower blood glucose and supports better metabolic function in those with insulin resistance or prediabetes.

• Reduces Visceral Fat: Particularly effective in targeting hard-to-lose abdominal and organ-surrounding fat.

• Supports Long-Term Weight Maintenance: Helps regulate appetite and cravings while maintaining lean muscle mass during weight loss.

Usage Overview:

Retatrutide is administered via subcutaneous injection, typically once per week. Dosing should be titrated and monitored under medical supervision to manage tolerability and optimize results. It is ideal for individuals with obesity, metabolic syndrome, or type 2 diabetes seeking advanced support for weight loss and metabolic health.